BioSpace News Archive

Global health care spending is projected to increase from US$ 6.5 Trn in 2012 to US$ 10 Trn in 2020 at a compound annual growth rate of 5.5%.

Healthcare agencies around the world have appreciated the need for assisted living facility and related approaches for helping the affected make reentry into the mainstream.

The Healthcare Automatic Identification and Data Capture market may record considerable growth during the forecast period of 2019-2029 on the back of the growing need for error reduction in healthcare services.

The growth of bile duct cancer treatment market stems from rising incidence of bile duct cancer, as the average age of the world population increases.

Nordic Nanovector ASA announces that it enrolled the final two patients into the second safety cohort of its Phase 1 Archer-1 trial investigating safety and preliminary efficacy of Betalutin® in combination with rituximab in 2nd-line follicular lymphoma.

Lysogene, a phase 3 gene therapy platform Company targeting central nervous system diseases, reports its cash position as of 30 September 2020.

Evotec SE presents the progress made in accelerating its co-owned pipeline and its global infrastructure “The R&D Autobahn to Cures”.

Women who experience food or housing insecurity may be at risk for undiagnosed breast cancer due to lapses in follow-up appointments, according to research being presented at the annual meeting of the Radiological Society of North America.

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on December 1-2, 2020.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced financial and operating results for the quarter ended September 30, 2020